Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Multiple sclerosis

Recruiting

Registered drugNo placebo

Indapamide for Reducing Disability Progression in Adults with Primary and Secondary Progressive Multiple Sclerosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:INDAPAMIDE HEMIHYDRATE

Contact Research Centre

Multiple sclerosis

Recruiting

InvestigationalNo placebo

Safety and Feasibility of Home Use On-Body Injection System for Subcutaneous Ocrelizumab in Adults with Multiple Sclerosis

InvestigationalNo placebo

France

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Multiple sclerosis+1

Recruiting

Registered drugNo placebo

Randomized Study of Tolebrutinib Versus Rituximab in Adults with Multiple Sclerosis

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Multiple sclerosis

Recruiting

InvestigationalNo placebo

A study to compare the effectiveness and safety of subcutaneous frexalimab versus intravenous frexalimab in adults with multiple sclerosis

InvestigationalNo placebo

Belgium

Participants:18–64 years
Substances:Frexalimab

Contact Research Centre

Multiple sclerosis

Recruiting

Registered drug

A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

Registered drug

France

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Multiple sclerosis

Recruiting

Registered drugNo placebo

Study of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:ACICLOVIR SODIUM

Contact Research Centre

Multiple sclerosis

Recruiting

Investigational

Study of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis

Investigational

Czechia

Participants:18–64 years · 65+ years

Contact Research Centre

Multiple sclerosis+1

Recruiting

Investigational

Study on the Effects of THC and CBD Oral Solution for Chronic Neuropathic Pain in Multiple Sclerosis Patients

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Cannabidiol

Contact Research Centre

Multiple sclerosis

Recruiting

InvestigationalNo placebo

Study of [18F]-DPA-714 PET imaging to assess neuroinflammation in multiple sclerosis patients compared to healthy controls

InvestigationalNo placebo

France

Participants:18–64 years · Healthy volunteers
Substances:N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide

Contact Research Centre

Multiple sclerosis

Recruiting

Registered drugNo placebo

Study on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dimethyl Fumarate

Contact Research Centre

Multiple sclerosis

Recruiting

Registered drugNo placebo

Study on Monitoring Ocrelizumab Levels for Personalized Treatment in Patients with Relapsing-Remitting and Primary Progressive Multiple Sclerosis

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Ocrelizumab

Contact Research Centre

Multiple sclerosis+2

Recruiting

Registered drugNo placebo

Study on the Effects of Ozanimod on Inflammation in Patients with Relapsing Multiple Sclerosis

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ozanimod

Contact Research Centre

Find therapies in clinical trials near you

59 trials match your criteria

Multiple sclerosis

Indapamide for Reducing Disability Progression in Adults with Primary and Secondary Progressive Multiple Sclerosis

Multiple sclerosis

Safety and Feasibility of Home Use On-Body Injection System for Subcutaneous Ocrelizumab in Adults with Multiple Sclerosis

Multiple sclerosis+1

Randomized Study of Tolebrutinib Versus Rituximab in Adults with Multiple Sclerosis

Multiple sclerosis

A study to compare the effectiveness and safety of subcutaneous frexalimab versus intravenous frexalimab in adults with multiple sclerosis

Multiple sclerosis

A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

Multiple sclerosis

Study of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration

Multiple sclerosis

Study of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis

Multiple sclerosis+1

Study on the Effects of THC and CBD Oral Solution for Chronic Neuropathic Pain in Multiple Sclerosis Patients

Multiple sclerosis

Study of [18F]-DPA-714 PET imaging to assess neuroinflammation in multiple sclerosis patients compared to healthy controls

Multiple sclerosis

Study on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis

Multiple sclerosis

Study on Monitoring Ocrelizumab Levels for Personalized Treatment in Patients with Relapsing-Remitting and Primary Progressive Multiple Sclerosis

Multiple sclerosis+2

Study on the Effects of Ozanimod on Inflammation in Patients with Relapsing Multiple Sclerosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.